VivoSeq
Other

Arterial Stiffness

0

Pipeline Programs

3

Active Trials

1

Companies Involved

Arterial Stiffness is an early-stage landscape with 0 programs across 1 company. The most active players are GSK.

Pipeline Metrics

Competitive Density

14/100

Pipeline Velocity

0/100

Mech. Concentration

N/A

Completion Rate

93/100

Attrition Rate

6/100

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

Programs by Phase

No pipeline programs currently tracked for this disease.

Trial Status

18

clinical trials

Completed13 · 72%
Recruiting3 · 17%
Unknown status1 · 6%
Terminated1 · 6%

Trial Activity

18 trials

ENAC Blockade and Arterial Stiffness
Completed·UUniversity of Missouri-Columbia·Phase 2/3·NCT03837626·137 enrolled
Atorvastatin Effects On Arterial Stiffness In Hemodialysis
Completed··Phase 2·NCT04472637·50 enrolled
The Effect of Anacetrapib on Vascular Function and Arterial Stiffness
Completed··N/A·NCT02931188·103 enrolled
Page 1 of 2

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)